Literature DB >> 15994732

Clinical trials during the prodromal stage of schizophrenia.

Jean Addington, Donald Addington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15994732     DOI： 10.1176/appi.ajp.162.7.1387

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

Authors:  Anthony P Morrison; Paul French; Sophie Parker; Morwenna Roberts; Helen Stevens; Richard P Bentall; Shôn W Lewis
Journal:  Schizophr Bull       Date:  2006-09-14       Impact factor: 9.306

Review 2.  Cognitive behavioral therapy in prodromal psychosis.

Authors:  Jean Addington; Catherine Marshall; Paul French
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents.

Authors:  Lesley J Scott; Sohita Dhillon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 4.  Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review.

Authors:  Stefano Barlati; Giacomo Deste; Alessandro Galluzzo; Anna Paola Perin; Paolo Valsecchi; Cesare Turrina; Antonio Vita
Journal:  Front Pharmacol       Date:  2019-01-10       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.